|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2001;72:1154
© 2001 The Society of Thoracic Surgeons
a Centre de Pneumologie de lHôpital Laval, Thoracic Surgery 2725, Chemin Sainte-Foy, Sainte-Foy, QC G1V 4G5, Canada
In this paper, Martin and associates analyze the risk of pulmonary resection done for lung cancer in the context of induction (neoadjuvant) therapy. The number of cases included in the series is very significant and is certainly a tribute to the pioneer work in this field of Dr Nael Martini. Overall, the operative mortality (3.8%) and morbidity (38.1%) are similar to what would be expected after pulmonary resection done without induction chemoradiation.
Obviously, the real "eye-opener" in this paper
Related Article
Ann. Thorac. Surg. 2001 72: 1149-1154.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |